Contralateral Claims Study of Clareon Vivity Pro

Contralateral Claims Study of Clareon Vivity Pro

The purpose of this study is to test new versions of Clareon Vivity Pro intraocular lenses (IOLs) by comparing them to currently marketed IOLs.

Two sub-studies will be conducted. In Sub-Study B, Clareon Vivity Pro will be compared to Clareon Vivity. In Sub-Study C, Clareon Vivity Pro will be compared to TECNIS PureSee.

This study will be conducted in Australia.

Key Inclusion Criteria:

• Cataracts in both eyes.
• Preoperative corneal astigmatism of less than 1.00 diopter (D) in each eye.
• Potential postoperative best corrected visual acuity (BCDVA) of 0.2 logMAR or better in each eye in the expert medical opinion of the investigator.
• Other protocol-defined inclusion criteria may apply.

Key Exclusion Criteria:

• Desires monovision correction.
• Predicted post-operative residual astigmatism of more than 1D in either eye.
• Any ocular or systemic co-morbidity that, in the investigator's medical opinion, may confound the results of this study, prohibit the completion of the study assessments, or increase the risk for the subject.
• Other protocol-defined exclusion criteria may apply.